In vitro cytotoxic activity of lithotripter shock waves combined with Adriamycin or with cisplatin on L1210 mouse leukemia cells
- 1 June 1989
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 115 (3) , 229-234
- https://doi.org/10.1007/bf00391694
Abstract
The effect of a combined treatment with shock waves generated by a lithotripter and Adriamycin or cisplatin was examined in cells that acutely survived exposure to shock waves and proliferated afterwards. Batches of 2 x 106 cells were exposed to the respective drug for 50 min or for 50 min plus 72 h. During the 50-min drug exposure 500 shock waves were applied at 25 kV. The growth as a percentage of the control was determined after 72 h by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Cells treated with shock waves alone showed a growth inhibition as compared to control cells. For a 50-min drug exposure with Adriamycin the dose enhancement ratio did not exceed 1.3. For a 50-min drug exposure with cisplatin at concentrations of 0.5 μg/ml and 5.0 μg/ml, growth (as a percentage of the control) after combined treatment was significantly reduced as compared to cisplatin treatment alone; the dose enhancement ratio was 3.2 at 50% growth compared to the control. This indicates that shock waves can increase the susceptibility of L1210 cells to cisplatin. For a 50-min plus 72-h drug exposure no effect of an additional treatment with shock waves, as compared to chemotherapy alone, could be observed.This publication has 26 references indexed in Scilit:
- Biological effects of shock waves: Kidney damage by shock waves in dogs—Dose dependenceUltrasound in Medicine & Biology, 1988
- Acoustic cavitation generated by an extracorporeal shockwave lithotripterUltrasound in Medicine & Biology, 1987
- Rapid colorimetric assay for cell growth and survivalJournal of Immunological Methods, 1986
- Fragmentation of Gallstones by Extracorporeal Shock WavesNew England Journal of Medicine, 1986
- Cellular transport of anthracyclines by passive diffusion: Implications for drug resistanceBiochemical Pharmacology, 1985
- Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNABiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering CellsScience, 1982
- Membrane transport of anthracyclinesPharmacology & Therapeutics, 1982
- Reproducible subcellular alterations in hepatocytes resulting from ultrasoundUltrasound in Medicine & Biology, 1980